Signaling pathways
-
BA4437 ErtiprotafibSummary: Ertiprotafib is an inhibitor. - BA4438 IndeglitazarSummary: Indeglitazar (PPM204) is an orally active pan agonist with acting activity against PPARα, and...
- BA4439 BilobetinSummary: Bilobetin is an active ingredient that lowers blood lipids and improves insulin action.
- BA4440 LY518674Summary: LY518674 (LY-674) is a potent and selective agonist.
- BA4441 BocidelparSummary: Bocidelpar is a regulator.
- BA4442 MonascinSummary: Monascin is an azurophilic pigment that can be extracted from red yeast rice and is orally active with antitumor and anti-inflammatory activities.
- BA4443 BAY-4931Summary: BAY-4931 is a potent, covalent, selective inverse agonist.
- BA4444 PPARγ-IN-2Summary: PPARγ-IN-2 is an inhibitor.
- BA4445 AMG131Summary: AMG131 (INT131) is a potent and highly selective partial agonist that binds to, and replaces, rosiglitazone at ~10nM.
- BA4446 BAY-0069Summary: BAY-0069 is a potent and selective inverse activator at 6.3 nM and 24 nM for human and mouse, respectively.